GRAIL, Inc. (GRAL)
50.23
-1.57
(-3.03%)
USD |
NASDAQ |
Mar 06, 16:00
50.50
+0.27
(+0.54%)
After-Hours: 20:00
GRAIL EPS Diluted (Quarterly) : -2.435 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3058 |
| Interpace Biosciences, Inc. | 0.0329 |
| Thermo Fisher Scientific, Inc. | 5.210 |
| XWELL, Inc. | -0.2557 |
| Hypha Labs, Inc. | -0.0034 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -99.18M |
| Revenue (Quarterly) | 43.60M |
| Total Expenses (Quarterly) | 142.77M |
| Enterprise Value | 1.176B |
| Gross Profit Margin (Quarterly) | -25.54% |
| Profit Margin (Quarterly) | -227.5% |
| Earnings Yield | -22.26% |
| Normalized Earnings Yield | -21.17 |